The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan
Ada Braun(National Cancer Centre Japan), U. Vanhoefer, Katrin Stark(West Cancer Center), Olaf Dirsch(Unfallkrankenhaus Berlin), S. Seeber, Ralf A. Hilger(West Cancer Center)
Cited by 30
Related Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
|European Journal of Cancer|2012|588
Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor
|Journal of Clinical Oncology|2003|259
Denosumab for Treatment of Hypercalcemia of Malignancy
|The Journal of Clinical Endocrinology & Metabolism|2014|200